| Ytd | -12.63% | |
| 1y | -55.97% |
| Open | 3.39 | Prev Close | 3.34 | Low | 3.39 | High | 3.39 | Mkt Cap | 18.05M |
| Vol | 767.00 | Avg Vol | 66.13K | EPS | -11.06 | P/E | -0.30 | Forward P/E | N/A |
| Beta | 0.74 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-17 | 50-d Avg | 4.41 | 200-d Avg | 5.23 | 1yr Est | 0.00 |
Neuphoria Therapeutics Inc. ("Neuphoria" or the "Company") (NASDAQ:NEUP), a clinical
Major M&A deals this week include: LVMH agrees to sell Marc Jacobs to WHP Global, 365 Markets bu